[{"AccountsPayableCurrent_0_Q3_USD":30022000.0,"StockRepurchasedDuringPeriodValue_3_Q3_USD":104706000.0,"EarningsPerShareDiluted_1_Q3_USD":0.44,"EarningsPerShareDiluted_3_Q3_USD":0.49,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":178346000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-770000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":2285000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q3_USD":16.98,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":14.54,"StockRepurchasedDuringPeriodShares_3_Q3_shares":2691000.0,"ProceedsFromSaleOfAvailableForSaleSecurities_3_Q3_USD":39944000.0,"InterestIncomeExpenseNet_1_Q3_USD":3085000.0,"InterestIncomeExpenseNet_3_Q3_USD":10999000.0,"PaymentsToAcquireInvestments_3_Q3_USD":57418000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3_Q3_USD":100830000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":81794000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":7020000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":21138000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":37579000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":250607000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q3_shares":5490000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q3_USD":24065000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3_Q3_USD":39425000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":16808000.0,"ProvisionForDoubtfulAccounts_3_Q3_USD":2741000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":45125000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":54433000.0,"DeferredRevenueCurrent_0_Q3_USD":6179000.0,"OperatingLeaseExpense_3_Q3_USD":2652000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":909000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":5105000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_0_Q3_USD":46.85,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q3_USD":53130000.0,"DeferredIncomeTaxAssetsNet_0_Q3_USD":4620000.0,"DeferredIncomeTaxesAndTaxCredits_3_Q3_USD":-4458000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":45970000.0,"IncomeTaxesReceivable_0_Q3_USD":8097000.0,"OtherNonoperatingIncome_1_Q3_USD":202000.0,"OtherNonoperatingIncome_3_Q3_USD":595000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":44121000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q3_USD":23268000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3_Q3_USD":63686000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":98453000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":16876000.0,"AvailableForSaleSecuritiesNoncurrent_0_Q3_USD":275587000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":1231000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":526000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":335000.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"OperatingLeaseLiability_0_Q3_USD":4255000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1645000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":2610000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":4255000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":676000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.03,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":2820000.0,"OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_3_Q3_USD":5821000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_3_Q3_USD":31991000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_3_Q3_USD":716000.0,"ResearchAndDevelopmentInProcess_3_Q3_USD":24418000.0,"SalesAndExciseTaxPayableCurrent_0_Q3_USD":3800000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_1_Q3_USD":7007000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_3_Q3_USD":21335000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":1679000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_3_Q3_USD":-215000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":506000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":4590000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q3_USD":-170000.0,"ForeignCurrencyTransactionGainLossBeforeTax_3_Q3_USD":-806000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q3_shares":2268000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3_Q3_shares":2370000.0,"AccruedRoyaltiesCurrent_0_Q3_USD":2656000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":7007000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":159030000.0,"BusinessCombinationAcquisitionRelatedCosts_1_Q3_USD":1263000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q3_USD":136000.0,"BusinessCombinationAcquisitionRelatedCosts_3_Q3_USD":1867000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":379000.0,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_1_Q3_USD":-13000.0,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_3_Q3_USD":197000.0,"GoodwillForeignCurrencyTranslationGainLoss_3_Q3_USD":1010000.0,"GoodwillOtherIncreaseDecrease_3_Q3_USD":-123000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_3_Q3_USD":-105000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":3749000.0,"InventoryWriteDown_3_Q3_USD":12411000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":54883000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":98217000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":47.41,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":117826000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":118609000.0,"NetIncomeLoss_1_Q3_USD":44216000.0,"NetIncomeLoss_3_Q3_USD":49328000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":49595000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":19091000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":215274000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":992125000.0,"Revenues_1_Q3_USD":216098000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":1770000.0,"Revenues_3_Q3_USD":555597000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":61803000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CommonStockSharesAuthorized_0_Q3_shares":775000000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":51092000.0,"OperatingExpenses_1_Q3_USD":108988000.0,"OperatingExpenses_3_Q3_USD":346095000.0,"OperatingIncomeLoss_1_Q3_USD":50013000.0,"OperatingIncomeLoss_3_Q3_USD":52898000.0,"StockholdersEquity_0_Q3_USD":1417204000.0,"PaymentsForRepurchaseOfCommonStock_3_Q3_USD":104669000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":-65875000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":1541739000.0,"AccountsReceivableNetCurrent_0_Q3_USD":143268000.0,"AccruedIncomeTaxesCurrent_0_Q3_USD":979000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":2207000.0,"AdditionalPaidInCapital_0_Q3_USD":422774000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":5101000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":6130000.0,"Assets_0_Q3_USD":1541739000.0,"AssetsCurrent_0_Q3_USD":811951000.0,"LiabilitiesCurrent_0_Q3_USD":99980000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":250607000.0,"GrossProfit_3_Q3_USD":398993000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":8914000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":14358000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":5401000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":-8412000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":4381000.0,"InventoryNet_0_Q3_USD":231858000.0,"Liabilities_0_Q3_USD":124535000.0,"GrossProfit_1_Q3_USD":159001000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":14421000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":69278000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":89152000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":39.5,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":28.69,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":52.43,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3_Q3_USD":1027000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":3931000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":57097000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":156604000.0,"EarningsPerShareBasic_1_Q3_USD":0.45,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":10694000.0,"EarningsPerShareBasic_3_Q3_USD":0.5,"Goodwill_0_Q3_USD":129662000.0,"LitigationSettlementExpense_3_Q3_USD":197000.0,"OtherAssetsNoncurrent_0_Q3_USD":22851000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":93761000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":5204000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":31.71,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":488000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":2071000.0,"GainLossOnDispositionOfAssets1_3_Q3_USD":-714000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":10788000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":3117000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":81794000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":262710000.0,"ShareBasedCompensation_3_Q3_USD":21138000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":1539000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":28157000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":100485000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":100823000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":267364000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q3_USD":7011000.0,"AmortizationOfIntangibleAssets_1_Q3_USD":4152000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":12043000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q3_USD":4128000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q3_pure":0.168,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.225,"IncomeTaxesPaid_3_Q3_USD":19328000.0,"IncreaseDecreaseInInventories_3_Q3_USD":47271000.0,"InventoryRawMaterials_0_Q3_USD":34198000.0,"InventoryWorkInProcess_0_Q3_USD":19314000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":1515000.0,"FiniteLivedIntangibleAssetsGross_0_Q3_USD":132886000.0,"StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_0_Q3_USD":95294000.0,"TreasuryStockAcquiredAverageCostPerShare_3_Q3_USD":38.91,"Ticker":"GMED","CIK":"1237831","name":"GLOBUS MEDICAL INC","OfficialName":"Globus Medical Inc. Class A Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"7998717137.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NYSE","SP500":"nan","filed":"20201028"}]